Product
Sustainability
Development
For patients
News
About us
- Team
- Contact

Search

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search

Senaste inläggen

Gedea Biotech announces the start of the clinical study VVC2025—first patients enrolled
Gedea Biotech strengthens IP portfolio with new European patent for treating infections with GDL
Gedea Biotech strengthens IP portfolio with new US patent for vaginal formulation
Gedea Biotech appoints Julie Waras Brogren as new CEO to lead the company into its commercialization phase
Gedea Biotech announce start of the clinical study BV2025 following CE marking of pHyph —first patients enrolled

Senaste kommentarer

No comments to show.

Arkiv

Kategorier

Okategoriserade

© 2026 Gedea Biotech. All rights reserved